Your Input: | |||||
| ENSOCUP00000041377 | Ig-like domain-containing protein. (148 aa) | ||||
| LOC100349667 | Ig-like domain-containing protein. (292 aa) | ||||
| IL13 | Interleukin 13. (138 aa) | ||||
| HLA-DQB2 | Major histocompatibility complex, class II, DQ beta 1. (305 aa) | ||||
| ENSOCUP00000046413 | MHC_II_beta domain-containing protein. (169 aa) | ||||
| CD40LG | CD40 ligand; Cytokine that acts as a ligand to CD40/TNFRSF5. Costimulates T-cell proliferation and cytokine production. Involved in immunoglobulin class switching. (261 aa) | ||||
| IL5 | Interleukin-5; Factor that induces terminal differentiation of late- developing B-cells to immunoglobulin secreting cells. (134 aa) | ||||
| CCL11 | SCY domain-containing protein. (96 aa) | ||||
| IL9 | Interleukin 9. (143 aa) | ||||
| TNF | Tumor necrosis factor, membrane form; Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation (By similarity). Induces insulin resistance in adipocytes via inhibition of insulin-induced IRS1 tyrosine phosphorylation and insulin-induced glucose uptake. Induces [...] (234 aa) | ||||
| PRG2 | C-type lectin domain-containing protein. (229 aa) | ||||
| HLA-DPB1 | RLA class II histocompatibility antigen, DP beta chain. (253 aa) | ||||
| MS4A2 | Membrane spanning 4-domains A2. (243 aa) | ||||
| HLA-DRA | Integral membrane protein; Belongs to the MHC class II family. (255 aa) | ||||
| EPX | Eosinophil peroxidase. (715 aa) | ||||
| HLA-DMA | Major histocompatibility complex, class II, DM alpha; Belongs to the MHC class II family. (234 aa) | ||||
| IGHM-2 | Ig-like domain-containing protein. (167 aa) | ||||
| IL10 | Interleukin-10; Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. Mechanistically, IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3. In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators. Targets antigen-presenting cells (APCs) such as macrophages and monocytes and inhibits their release of pro-inflammatory cytokines in [...] (304 aa) | ||||
| FCER1A | Fc fragment of IgE receptor Ia. (245 aa) | ||||
| RLA-DMB | Ig-like domain-containing protein. (257 aa) | ||||
| G1TYN5_RABIT | Ig-like domain-containing protein. (119 aa) | ||||
| HLA-DOB | Major histocompatibility complex, class II, DO beta. (265 aa) | ||||
| IL4 | Interleukin-4; Participates in at least several B-cell activation processes as well as of other cell types. It is a costimulator of DNA-synthesis. It induces the expression of class II MHC molecules on resting B-cells. It enhances both secretion and cell surface expression of IgE and IgG1. It also regulates the expression of the low affinity Fc receptor for IgE (CD23) on both lymphocytes and monocytes. Positively regulates IL31RA expression in macrophages. Stimulates autophagy in dendritic cells by interfering with mTORC1 signaling and through the induction of RUFY4; Belongs to the IL- [...] (144 aa) | ||||
| IGHM-3 | Ig-like domain-containing protein. (167 aa) | ||||
| FCER1G | Fc fragment of IgE receptor Ig. (85 aa) | ||||
| CD40 | Uncharacterized protein. (494 aa) | ||||
| ENSOCUP00000035377 | Ig-like domain-containing protein. (160 aa) | ||||
| ENSOCUP00000037393 | Uncharacterized protein. (92 aa) | ||||